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SUMMARY 
Renal functions of 30 patients of manic depressive psychosis on long term lithium prophylaxis have been 
studied and compared with 15 age and sex matched patients receiving psychotropic drugs other than lithium. The 
urine output more than 2.5 L/day was seen in 12 patients (4(1% ) while impaired capacity to show urinary osmol-
ality more than 500 m Osm/L after overnight fluid deprivation was seen in 6 patients. Creatinine clearance ranged 
between 70-106 ml/min (mean 89 ml/mt). Creatinine clearance less than 70 ml/nun was seen in 3 patients. The 
ratio of urinary and serum creatinine showed statistically significant (p<.U01) low value in lithium treated group. 
There was also significant increase in mean uric acid excretion in patients on lithium therapy. It is recommended 
that inspite of serum lithium levels being in normal range, renal functions should be assessed regularly in order to 
avoid progressive impairment of renal functions. 
Introduction 
Lithium has been accepted as the 
most effective prophylactic therapy in pa-
tients with recurrent manic depressive 
psychosis and is commonly used (Prien et 
al. 1972). However during the last few 
years the main interest has been focussed 
on hazards involved in this therapy. Vari-
ous studies have reported side effects of 
long term lithium mainly on thyroid (Vil-
leneuve et al. 1974) and kidney (Hallgren 
et al. 1979, Myres et al. 1980, Vestergaard 
et al. 1979). Among the known side effects 
of Lithium on kidney functions, impaired 
ability to concentrate the urine during 
water deprivation or vasopressin resistant 
diabetes insipidus like syndrome (which is 
progressive and reversible) is most fre-
quent (Uldall 1979). Hestbech et al. 
(1977) and Venkoba Rao et al. (1981) re-
ported interstitial lesions in the renal 
biospy specimens of patients receiving 
lithium for many years. In order to avoid 
serious impairment of renal function lower 
doses of lithium are now recommended 
(Vestergaard et al. 1979). Although 
lithium is being used in many psychiatric 
centres in India, data regarding its long 
term effects are still scanty. Prompted by 
these reports of the drug's nephrotoxic ef-
fects, we assessed the renal function of a 
number of patients receiving long term 
lithium therapy. 
Material and Methods 
The present study was conducted at 
Department of Psychiatry of Smt. Sucheta 
Kriplani Hospital, New Delhi. Included 
1.&2. Senior Resident 
3. Research Scholar 
5. Associate Professor 
6. Professor and Head 
4. Senior Resident, Department of Pathology 
Department of Psychiatry, Lady Hardinge Medical College and associated 
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in the study were 58 patients of affective 
disorder on lithium prophylaxis for more 
than one year (Group A). Out of these. 
2S cases did not turn up for various tests 
and hence had to be excluded from the 
studv (so total number of patients in-
eluded in the study for final analysis were 
30). Their ages varied from 26 to 55 years 
(mean 36.S year). The duration of 
lithium therapy varied from 1 to 6 years 
with a mean of 2.4 years The daily dose 
varied from 45(1- 1200 mg with a mean of 
MOO mg. Serum lithium was estimated at 
least once in two months and serum 
lithium levels were maintained between 
0.6 and 1.2 m Hq / L. The patients hav-
ing irregular intake of lithium or concur-
rent neuroleptic medication or physical 
illness were excluded from the study. 15 
age and sex matched patients constituted 
the control group and were subjected to 
similar tests (Group B). 
Renal Function tests 
Twenty four hour urinary volume: 
24 hour urine samples were collected 
under strict supervision on two consecu-
tive ila\s and the mean daily urinarv out-
put was calculated. Polyuria was consi-
dered when the mean urinary output was 
more than 2.5 litres per day. 
Urinary specific gravity and osmol-
ality were measured after 12 hours of 
overnight fluid deprivation. Apparent 
defect in concentration was considered 
when specific gravity more than 1016 and 
osmolality more than 500 m Osm / L 
could not be achieved. Specific gravity 
was measured bv a densitometer and os-
molality by Flask Osmometer. Urinary 
pH was measured in fresh morning 
sample. 
Blood urea was estimated by 
Diacetyl Monoxime method and serum 
sodium, potassium, lithium by Flame 
Photometer (Hald 1951). urinary sodium 
and potassium by Flame Photometer, 
serum and urinarv creatinine by Jaffe 
Reaction, serum and urinary uric acid, 
and routine macroscopic and micros-
copic examination of urine was carried 
out in all cases. 
Results 
None of the patients showed any 
glycosuria or proteinuria. Microscopic 
examination of urine also did not show 
anv abnormality in any of the cases. 
Blood urea and serum electrolytes were 
within normal range. 
12 (40%) lithium treated patients 
showed a daily urinary output exceeding 
2.5 litres (out of these. 11 patients had 
urine output in range of 2.7 to 4.5 L/d while 
one patient had urine volume 6.1 L/d. Six 
patients (20''<>) failed to concentrate urine 
above 500 m Osm/L after overnight fluid 
deprivation. After 12 hour dehydration, in 
group A. 12 patients had specific gravity 
(SG) less than 1016 and the lowest SG 1009 
was observed in one patient with urine vol-
ume 6KM) ml/d. his creatinine clearance 
was 50.07 ml/mt. serum creatinine was 
highest (1.47 mg%) but there was no ap-
parent clinical sign of renal failure. None 
of the patients in group B had SG less than 
1016. The pH of morning sample of urine 
varied from 5.56 to 7.12 which did not 
reach the level of statistical significance 
when compared with control group. 
Serum creatinine varied between 0.7 
to 1.47mg/dl. Mean 24 hours urinary 
creatinine values of each group was within 
normal range. The range of creatinine 
clearance (ml/mt) of group A and B were 
43.52 to 122.25 and SO.02 to 125.65 respec-
tively Only three patients on lithium had 
creatinine clearance less than 70 ml/mt. 
The patient having creatinine clearance N.K. DHARETAL.  81 
H).01 was on lithium for 1 V2 years and had 
the maximum urinary output of 6100 ml/24 
hours, the lowest SG and highest serum 
lithium levels. The patient having 
creatinine clearance 43.52 was 52 years old 
and was on lithium for 48 months, his uri-
nary output was 3720 and specific gravity 
1010. Third patient having creatinine 
clearance 56.08 was on lithium for 11 
months and was having polyuria (urine 
volume 4500 ml/24 hrs.) and SG was 1012. 
Serum uric acid and 24 hours urinary 
proteins of group A and B patients did not 
show any abnormality. 
Discussion 
In the present study, 40 per cent of the 
patients on lithium showed a concentra-
tion defect while 20% of these developed 
significant polyuria (> 3L / d). Polyuria in 
lithium treated group has also been re-
ported by Cattell et al. (1978), Forrest et 
al. (1974), Vestergaard et al. (1979), 
Walker et al. (1981), Hetmaretal. (1986) 
in 4, 13, 30, 10 and 85 per cent of cases re-
spectively. A number of probable explana-
tions have been tendered to explain 
lithium induced polyuria. Firstly, lithium 
inhibits the ADH synthesis and storage at 
central level (Singer et al. 1972, Forrest et 
al. 1974). Secondly, lithium impairs the 
renal concentrating capacity by virtue of 
both ADH dependent (mediated mainly 
through cyclic AMP) and ADH indepen-
dent mechanism (Singer and Franko 
1973). Thirdly, polyuria has been de-
scribed as the result of direct action of 
lithium on collecting ducts (Hochman and 
Gutman 1974). Some other studies (Khan-
delwal et al. 1984. Sethi et al. 1987) did not 
find increase in 24 hours urinary volume in 
lithium treated patients in comparison to 
control group. 
The inability to concentrate urine 
above 500 mOsm / L, as was also re-
ported by Hansel et al. 1979), Wahlin et al. 
(1980). Walker et al. (1982). Plenge et al. 
(1982), was found in 20 per cent cases. The 
striking observation in the present study 
was the concurrent presence of polvuria 
and impaired concentration ability in 50 
per cent polyuric patients. Out of these, 
two patients did not show deficit in con-
centration abilitv on estimation of specific 
gravity. This may be ascribed to the uri-
nary excretion of more molar substances 
like urea and certain non-reducing sugars, 
which may increase the specific gravity in-
spite of polyuria. 
Mean GFR as measured by creatinine 
clearance did not show any significant 
change among the groups. However, re-
duced creatinine clearance (less than 90 
ml / mt) was seen in 40 per cent cases in 
lithium group. Similarly Uldall et al. 
(1981), Albrecht et al. (1980) and Bendzet 
al. (1983) observed reduced creatinine 
clearance in 17. 30 and 30 per cent patients 
respectively. Several other workers (Ul-
dall et al. 1980. Venkoba Rao et al. 1981, 
Jensen and Rickers 1984, Bendz 1985) 
have reported that the patients who have 
reduced GFR alter receiving long term 
lithium treatment, have been shown to 
have interstitial nephropathy. Vestergaard 
et al. (1979) suggested that if lithium treat-
ment affected glomerular function, it did 
so only moderately and slowly. No case of 
terminal renal failure due to long term 
lithium therapy had been reported so far. 
The ratio of urinary creatinine to 
plasma creatinine showed relatively low 
value in lithium treated Liroup i y o IKil i 
This indirectly suggests some degree of 
nephron loss, thereby decreasing clear-
ance of creatinine. Mean urinarv and 
plasma creatinine ratio in relation to uri-
nary sodium showed a significantly higher 
value in lithium group, thus suggesting loss 
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Table 
Renal Function in 30 treated and 15 control patients 
Test  Lithium Group 
(McaniS.D.) 
Control Group 
(Mean±S.D.) 
Serum Na*(meg/l.) 
Serum K (mcg/L) 
Serum uric acid I my"/,,) 
Serum creatinine lmg"») 
Blood inc.i inii:"") 
Urinarv Sodium (meq/l.) 
Urinarv I'ut.isMiiiii (meq/1.) 
Urinary < 'reatiuine U:in/24hrs) 
Urinarv Cue acid (niu'24hrs) 
Unnar\ I'n items I nig 24hrs) 
Creatinine clcaiancc (ml/mt) 
24 his ininar\ volume (ml) 
Mean specific pravity 
Urinarv pi I 
136.95 
3.92 
4.78 
0.99 
24.09 
94.24 
38.6(1 
1.22 
498.71 
99.52 
88.79 
2615.24 
1.016 
6.21 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
T 
± 
± 
f 
+ 
+ 
+ 
5.29 
.40 
1.23 
.19 
6.55 
11.68 
7.14 
.57* 
126.15* 
28.81 
18.80 
1107.95* 
.0037** 
.465 
134.33 
3.73 
4.22 
.99 
20.33 
85.48 
37.82 
1.48 
366.33 
97.5 
102.58 
1966.67 
1.019 
6.14 
+ 
± 
+ 
± 
± 
+ 
± 
± 
± 
± 
± 
+ 
± 
± 
4.68 
.15 
1.43 
.13 
6.35 
7.82 
9.42 
.29 
137.91 
26.79 
15.09 
1132.05 
.0014 
.49 
p valves  :0.05,  <().()! 
Mean serum and urinary sodium 
levels were found to be within normal 
range. This is also reported by Honker et 
al. (1979). Coppen et al. (1980), Khandel-
wal et al. (19X3). Absence of anv signific-
ant change in mean serum and urinary 
potassium was in accordance with Coppen 
et al. ( 1980), Sethi et al. (1987) but Zadeh 
and Zeller (1977) noted hypokalemia as-
sociated with cardiac arrvthmias in pa-
tients with lithium toxicity. For this , they 
gave the explanation that lithium induced 
natriuresis. m turn, causes hvperaldos-
teronism, which was responsible for 
kaliuresis and ultimately hypokalemia. 
As reported by Coppen et al. (1980), 
Waller et al (1985). Sethi et al. (1987). 
there was no increase in mean serum and 
24 hour urinary creatinine levels This is in 
contrast to other studies (Yestcrgaard et 
al. 1979. Hansen et al. 1979). which re-
ported increase in serum creatinine levels 
in patients on lithium. 
Increase in mean 24 hours uric acid 
excretion in patients on lithium for more 
than one year was found to be statistically 
significant. The precise mechanism re-
sponsible for increased uric acid excretion 
was probably due to involvement of proxi-
mal tubule, thereby decreasing reabsorp-
tion of uric acid. 
As reported by Coppen et al. (1980), 
mean urinary pH was found to be within 
normal limits, but Walker et al. (1982) re-
ported impaired acidifying capacity in pa-
tients on lithium therapy. In animals, there 
is decreased ability to lower urinary pH in 
response to acid loading (Nascimento et al. 
1977). This can be explained on the basis of 
structural change in the distal convuluted 
tubules leading to impaired excretion of 
H ^ ions or acid in the urine inspite of acid 
challenge of exogenous or endogenous na-
ture. 
In conclusion, we observed that even 
after average daily lithium dose of 900 mg 
and average serum lithium levels of 0.73 ± 
0.16 meq/L. 40 per cent lithium treated pa-
tients developed polyuria out of which 50 
per cent also showed impaired concentra-
tion ability. Reduced creatinine clearance 
as well as decreased ratio of urinarv to 
plasma creatinine were also found in pa-
tients taking lithium. This is indeed impor-N.K. DHARETAL.  83 
tant that lithium should be given for pro-
longed periods only in cases where it is ab-
solutely necessary and advantages of 
therapy outweigh the possible risks. 
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